Traws Pharma Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 20.6%.

Top 25 shareholders own 22.2% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
6.5%	Viriom Inc.	1,645,100	US$709.0k	0%	no data
4.13%	OrbiMed Advisors LLC	1,045,261	US$450.5k	0%	0.01%
3.76%	Nikolay Savchuk	952,219	US$410.4k	0%	no data
2.8%	The Vanguard Group, Inc.	708,618	US$305.4k	0%	no data
1.06%	Renaissance Technologies LLC	268,194	US$115.6k	34.9%	no data
0.98%	BlackRock, Inc.	248,878	US$107.3k	0%	no data
0.76%	Geode Capital Management, LLC	192,858	US$83.1k	0%	no data
0.41%	Steven Fruchtman	104,792	US$45.2k	40.1%	no data
0.29%	Two Sigma Advisers, LP	73,066	US$31.5k	-6.28%	no data
0.26%	Iain Dukes	66,687	US$28.7k	0%	no data
0.21%	State Street Global Advisors, Inc.	52,790	US$22.8k	0%	no data
0.16%	Mark Guerin	39,255	US$16.9k	9.11%	no data
0.15%	Two Sigma Investments, LP	37,987	US$16.4k	-3.57%	no data
0.15%	Citadel Advisors LLC	36,819	US$15.9k	0%	no data
0.12%	Northern Trust Global Investments	30,783	US$13.3k	0%	no data
0.084%	James Marino	21,334	US$9.2k	0%	no data
0.075%	Morgan Stanley, Investment Banking and Brokerage Investments	18,855	US$8.1k	0%	no data
0.066%	Viren Mehta	16,714	US$7.2k	0%	no data
0.054%	Beacon Pointe Advisors, LLC	13,776	US$5.9k	-51.7%	no data
0.05%	Mutual Advisors, LLC	12,700	US$5.5k	0%	no data
0.041%	Mark Gelder	10,487	US$4.5k	0%	no data
0.026%	Edmond de Rothschild Asset Management (France)	6,666	US$2.9k	0%	no data
0.02%	Vermillion & White Wealth Management Group LLC	5,133	US$2.2k	0%	no data
0.014%	Tower Research Capital LLC	3,487	US$1.5k	-1.75%	no data
0.013%	Mary Shoemaker	3,383	US$1.5k	0%	no data